GERN
Geron Corp
Price:  
4.66 
USD
Volume:  
12,880,477.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-298.9%
Upside

As of 2024-07-27, the Relative Valuation of Geron Corp (GERN) is (9.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.66 USD, the upside of Geron Corp based on Relative Valuation is -298.9%.

The range of the Relative Valuation is (4.86) - (9.37) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.3x - 31.4x 30.8x
Forward P/E multiples 12.6x - 27.6x 23.8x
Fair Price (4.86) - (9.37) (9.27)
Upside -204.2% - -301.0% -298.9%
4.66 USD
Stock Price
(9.27) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2024-07-26 -13.72
2024-07-25 -12.63
2024-07-24 -12.63
2024-07-23 -13.61
2024-07-22 -13.78
2024-07-19 -13.55
2024-07-18 -13.75
2024-07-17 -14.02
2024-07-16 -14.70
2024-07-15 -14.43
2024-07-12 -13.87
2024-07-11 -14.02
2024-07-10 -13.55
2024-07-09 -13.49
2024-07-08 -13.34
2024-07-05 -13.34
2024-07-03 -12.84
2024-07-02 -12.28
2024-07-01 -12.78
2024-06-28 -12.49
2024-06-27 -13.08
2024-06-26 -13.11
2024-06-25 -13.31
2024-06-24 -13.52
2024-06-21 -13.69
2024-06-20 -13.13
2024-06-18 -13.22
2024-06-17 -13.75
2024-06-14 -14.34
2024-06-13 -14.37
2024-06-12 -14.99
2024-06-11 -14.99
2024-06-10 -14.84
2024-06-07 -13.52
2024-06-06 -11.46
2024-06-05 -11.78
2024-06-04 -11.75
2024-06-03 -11.28
2024-05-31 -10.45
2024-05-30 -10.22
2024-05-29 -9.78
2024-05-28 -9.87
2024-05-24 -10.25
2024-05-23 -10.28
2024-05-22 -10.78
2024-05-21 -10.90
2024-05-20 -10.98
2024-05-17 -11.22
2024-05-16 -11.49
2024-05-15 -11.49